Manish M. PatelMaritza PatziDarwin PastorAL NinaYelin RocaLuisa ÁlvarezVolga IñiguezRosario RiveraKa Ian TamOsbourne Quaye2026-03-222026-03-22201310.1136/bmj.f3726https://doi.org/10.1136/bmj.f3726https://andeanlibrary.org/handle/123456789/43458Citaciones: 87The monovalent rotavirus vaccine conferred high protection against hospital admission for diarrhea due to rotavirus in Bolivian children. Protection was sustained through two years of life against diverse serotypes different from the vaccine strain.enRotavirusOdds ratioMedicineRotavirus vaccineDiarrheaConfidence intervalVaccinationPediatricsCase-control studyConfoundingEffectiveness of monovalent rotavirus vaccine in Bolivia: case-control studyarticle